Elevance Health Appoints Nathan Rich Vice President, Investor Relations
05 November 2024 - 1:00AM
Business Wire
Elevance Health (NYSE: ELV) announced today the appointment of
Nathan Rich as Vice President, Investor Relations, effective
November 11, 2024. In this role, Mr. Rich will lead Elevance
Health's investor relations efforts, providing strategic leadership
to support the company’s growth initiatives and strengthen
relationships within the investment community. He will also serve
as a member of the company’s executive leadership team and will
report directly to Mark Kaye, Executive Vice President and Chief
Financial Officer. Mr. Rich succeeds Stephen Tanal, who now serves
as Chief Financial Officer for Elevance Health’s Government Health
Benefits business.
“Nate brings nearly two decades of experience spanning multiple
sectors, including managed care, healthcare services, and consumer
industries,” said Mark Kaye. “His diverse expertise, coupled with
his analytical acumen will be instrumental in driving our strategy
forward as we continue to evolve as a lifetime trusted health
partner.”
Prior to joining Elevance Health, Mr. Rich served as Vice
President in Global Investment Research at Goldman Sachs. He also
held roles of increasing responsibility at Citi as a sell-side
research analyst.
Mr. Rich holds a Bachelor of Science degree, magna cum laude,
from New York University’s Leonard N. Stern School of Business.
About Elevance Health
Elevance Health is a lifetime, trusted health partner whose
purpose is to improve the health of humanity. The company supports
consumers, families, and communities across the entire healthcare
journey – connecting them to the care, support, and resources they
need to lead better lives. Elevance Health’s companies serve
approximately 113 million consumers through a diverse portfolio of
industry-leading medical, pharmacy, behavioral, clinical, and
complex care solutions. For more information, please visit
www.elevancehealth.com or follow us @ElevanceHealth on X and
Elevance Health on LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241103351599/en/
Media Contact: Leslie Porras
Leslie.Porras@ElevanceHealth.com
Investor Relations: Investor.Relations@elevancehealth.com
Elevance Health (NYSE:ELV)
Historical Stock Chart
From Oct 2024 to Nov 2024
Elevance Health (NYSE:ELV)
Historical Stock Chart
From Nov 2023 to Nov 2024